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Breast cancer survival analysis using the Cox proportional model

Abstract
Breast cancer is one of the most common fatal cancers worldwide, with 12.5% of
the new cases diagnosed in 2020 [1]. The Computed Tomography, commonly
referred to as CT scan, is used to determine the breast cancer treatment and
prognosis of the cancer as it is challenging to detect. Breast cancer is common
in women, but sometimes can be seen in men as well. Although there are
models to predict Lung Cancer using the Convolutional Neural Network or
ConvNet (CNN) from the CT scans and clinical data [1], no such implementation
has been applied to the CT scans of the breast cancer using the images as well
as clinical data. Our achieved a c-index score of 0.635 on the test data being
25% of the whole data on the German Breast Cancer Study Group 2 dataset.

Introduction
Breast cancer is one of the largest morbidity and mortality of malignant tumor,
seriously endangers global female health [2]. The main goal of this work is to
predict the survival of the patient diagnosed with the Breast cancer. We have
used the Cox Proportional Hazard model and Kaplan Meier estimators with the
clinical data to predict the survival score of the patient in the next 5 years. This
work uses the clinical data of German Breast Cancer Study Group (GBSG2)
dataset with the features including hormonal therapy, age, menopausal status,
tumor size, tumor grade, number of postive nodes, progesterone receptor, and
estrogen receptor to predict the survival score using the Cox Proportional
Hazard model and visualize the Kaplan Meier plots for the survival of the
patient over a 5-year period.

Results

Conclusions

First we performed the kaplan-meier estimation on all the features in the dataset
and generated the plot shown in the Fig. 1.

This work used the Cox proportional hazard as the baseline model with the
concordance index or c-index as the evaluation metric and generated the Kaplan
Meier curves.

We then grouped the dataset into the two sets one with the patient undergoing
hormonal therapy and other not undergoing hormonal therapy and performed the
kaplan meier estimation on these separate sets and that generated
the plot shown in Fig. 2.

Our approach achieved the c-index score of 0.635 on the test data and a c-index
score of 0.702 on the training data. This work can be extended to different
models like Penalized Cox Models, Random Survival Forests, Gradient Boosted
Models, and Survival Support Vector Machine.

We also grouped the dataset by the menopausal status with the first group
having the data with post menopausal status and other with the pre menopausal
status and generated the kaplan-meier estimation curve on these groups showin
in the Fig. 3.
Finally, we tested our model using the c-index as the evaluation metric and it
achieved a c-index of 0.635 on test data and c-index of 0.702 on the training
data. We generated the synthetic data randomly and our model achieved the
c-index of 0.69
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It is very crucial to determine the aggressiveness of the tumor with the breast
cancer. This work will considers the clinical data to predict the survival score and
malignancy score that can help radiologists, oncologists, etc accurately predict
the breast cancer from the clinical data. This helps the oncologists to focus on
early treatment of the cancer instead of spending time determining the cancer
and it's survival and malignancy score.
We used the GBSG2: German Breast Cancer Study Group 2 dataset that has
686 samples and 8 features. We split the data as follows: 75% of the data about
514 samples for training and 25% of the data about 172 samples for testing the
model. We transformed the data using the ordinal encoder and standard scalar
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Fig. 2: Kaplan Meier estimation on Hormonal Therapy

Fig. 3: Kaplan Meier estimation on Menopausal Status
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